21 results
8-K
EX-10.1
OLMA
Olema Pharmaceuticals, Inc.
5 Sep 23
Olema Oncology Announces Combined Financing for Up to $180 Million
7:39am
principal supplier, manufacturer, customer or contractor of the Company, exists or, to the Company’s knowledge, is threatened or imminent. No executive
10-Q
txby7ukgdtzlxe6
11 May 21
Quarterly report
4:22pm
10-K
154tdvs
17 Mar 21
Annual report
4:21pm
424B4
fkcfijifzcvi j6g82
19 Nov 20
Prospectus supplement with pricing info
4:43pm
S-1/A
nru az73yf29r
16 Nov 20
IPO registration (amended)
6:06am
S-1/A
EX-1.1
096g55kwuabrx6
16 Nov 20
IPO registration (amended)
6:06am
S-1
qgnxp6 yk
30 Oct 20
IPO registration
2:29pm
DRS/A
imk ewe7k85z1i
23 Oct 20
Draft registration statement (amended)
12:00am